

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.24856309 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.49712107 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.49712107 |
| 4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.40418029 |
| 5 | negative T cell selection (GO:0043383) | 6.37983296 |
| 6 | positive thymic T cell selection (GO:0045059) | 6.14134524 |
| 7 | negative thymic T cell selection (GO:0045060) | 6.13465808 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 5.82340745 |
| 9 | positive T cell selection (GO:0043368) | 5.65240647 |
| 10 | thymic T cell selection (GO:0045061) | 5.49163100 |
| 11 | response to interleukin-15 (GO:0070672) | 5.44079222 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.40115174 |
| 13 | negative regulation of cell killing (GO:0031342) | 5.32853056 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.32853056 |
| 15 | interferon-gamma production (GO:0032609) | 5.25479809 |
| 16 | * positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.20946682 |
| 17 | T cell selection (GO:0045058) | 5.08456840 |
| 18 | cellular response to interleukin-15 (GO:0071350) | 4.81703935 |
| 19 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.80910306 |
| 20 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.59761070 |
| 21 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.55085524 |
| 22 | regulation of T cell tolerance induction (GO:0002664) | 4.53703294 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.51117250 |
| 24 | T cell migration (GO:0072678) | 4.33067047 |
| 25 | T cell receptor signaling pathway (GO:0050852) | 4.32602728 |
| 26 | tolerance induction (GO:0002507) | 4.27759862 |
| 27 | leukocyte aggregation (GO:0070486) | 4.26467559 |
| 28 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.24910926 |
| 29 | positive regulation of granulocyte differentiation (GO:0030854) | 4.16295785 |
| 30 | T cell costimulation (GO:0031295) | 4.04810391 |
| 31 | regulation of regulatory T cell differentiation (GO:0045589) | 3.99572022 |
| 32 | lymphocyte costimulation (GO:0031294) | 3.98642738 |
| 33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.96647342 |
| 34 | positive regulation of tolerance induction (GO:0002645) | 3.93748689 |
| 35 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.78450945 |
| 36 | positive regulation of isotype switching (GO:0045830) | 3.60818908 |
| 37 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.58945924 |
| 38 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.57898998 |
| 39 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.57812497 |
| 40 | activated T cell proliferation (GO:0050798) | 3.57407266 |
| 41 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.57027431 |
| 42 | morphogenesis of an endothelium (GO:0003159) | 3.56200380 |
| 43 | endothelial tube morphogenesis (GO:0061154) | 3.56200380 |
| 44 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.55645140 |
| 45 | negative regulation of interleukin-12 production (GO:0032695) | 3.53433434 |
| 46 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.52271923 |
| 47 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.51580187 |
| 48 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.51580187 |
| 49 | regulation of response to interferon-gamma (GO:0060330) | 3.50964615 |
| 50 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.48505393 |
| 51 | T cell homeostasis (GO:0043029) | 3.47913978 |
| 52 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.46221134 |
| 53 | * regulation of B cell receptor signaling pathway (GO:0050855) | 3.44101320 |
| 54 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.42412132 |
| 55 | * regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.39962226 |
| 56 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.39900947 |
| 57 | positive regulation of interleukin-2 production (GO:0032743) | 3.38982200 |
| 58 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.37832461 |
| 59 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.37832461 |
| 60 | regulation of tolerance induction (GO:0002643) | 3.36882019 |
| 61 | positive regulation of humoral immune response (GO:0002922) | 3.34450871 |
| 62 | positive regulation of B cell mediated immunity (GO:0002714) | 3.33810512 |
| 63 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.33810512 |
| 64 | mast cell activation (GO:0045576) | 3.32728075 |
| 65 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.29716929 |
| 66 | leukocyte cell-cell adhesion (GO:0007159) | 3.28229666 |
| 67 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.23590038 |
| 68 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.23193006 |
| 69 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.21161672 |
| 70 | Peyers patch development (GO:0048541) | 3.21161672 |
| 71 | negative regulation of T cell mediated immunity (GO:0002710) | 3.20368191 |
| 72 | response to type I interferon (GO:0034340) | 3.20239848 |
| 73 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.18596198 |
| 74 | T cell differentiation (GO:0030217) | 3.18105430 |
| 75 | regulation of isotype switching (GO:0045191) | 3.16197031 |
| 76 | positive regulation of B cell differentiation (GO:0045579) | 3.15081911 |
| 77 | type I interferon signaling pathway (GO:0060337) | 3.13453544 |
| 78 | cellular response to type I interferon (GO:0071357) | 3.13453544 |
| 79 | myeloid dendritic cell activation (GO:0001773) | 3.10746798 |
| 80 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.09945845 |
| 81 | regulation of alpha-beta T cell activation (GO:0046634) | 3.09521945 |
| 82 | alpha-beta T cell activation (GO:0046631) | 3.07274857 |
| 83 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.07103068 |
| 84 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.07089800 |
| 85 | modulation by symbiont of host immune response (GO:0052553) | 3.07089800 |
| 86 | positive regulation by symbiont of host defense response (GO:0052509) | 3.07089800 |
| 87 | modulation by symbiont of host defense response (GO:0052031) | 3.07089800 |
| 88 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.07089800 |
| 89 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.07089800 |
| 90 | NIK/NF-kappaB signaling (GO:0038061) | 3.05485253 |
| 91 | detection of other organism (GO:0098543) | 3.05223740 |
| 92 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.04406903 |
| 93 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.04253183 |
| 94 | lymphocyte homeostasis (GO:0002260) | 3.03129557 |
| 95 | regulation of B cell differentiation (GO:0045577) | 3.02909789 |
| 96 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.02717309 |
| 97 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.02717309 |
| 98 | positive regulation of DNA recombination (GO:0045911) | 3.02317340 |
| 99 | natural killer cell activation (GO:0030101) | 3.00560653 |
| 100 | detection of bacterium (GO:0016045) | 3.00224264 |
| 101 | regulation of B cell mediated immunity (GO:0002712) | 2.98867695 |
| 102 | T-helper cell differentiation (GO:0042093) | 2.95288606 |
| 103 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.95288606 |
| 104 | B cell receptor signaling pathway (GO:0050853) | 2.95243516 |
| 105 | alpha-beta T cell differentiation (GO:0046632) | 2.94130171 |
| 106 | regulation of granulocyte differentiation (GO:0030852) | 2.93447774 |
| 107 | lymphocyte migration (GO:0072676) | 2.93341571 |
| 108 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.92936294 |
| 109 | T cell activation (GO:0042110) | 2.92801389 |
| 110 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.92353051 |
| 111 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.91309821 |
| 112 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.90379521 |
| 113 | angiogenesis involved in wound healing (GO:0060055) | 2.90209235 |
| 114 | myeloid dendritic cell differentiation (GO:0043011) | 2.89292722 |
| 115 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.89073343 |
| 116 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.88307906 |
| 117 | natural killer cell differentiation (GO:0001779) | 2.87925852 |
| 118 | regulation of interleukin-2 production (GO:0032663) | 2.86491331 |
| 119 | negative regulation of adaptive immune response (GO:0002820) | 2.85872592 |
| 120 | T cell proliferation (GO:0042098) | 2.85805886 |
| 121 | cellular extravasation (GO:0045123) | 2.85283638 |
| 122 | regulation of cell killing (GO:0031341) | 2.84380379 |
| 123 | negative regulation of innate immune response (GO:0045824) | 2.83143189 |
| 124 | macrophage activation involved in immune response (GO:0002281) | 2.82329639 |
| 125 | positive regulation of lamellipodium assembly (GO:0010592) | 2.81685088 |
| 126 | lymph node development (GO:0048535) | 2.81235806 |
| 127 | neutrophil activation involved in immune response (GO:0002283) | 2.81177156 |
| 128 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.75642790 |
| 129 | leukocyte tethering or rolling (GO:0050901) | 2.75518595 |
| 130 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.74652636 |
| 131 | hepatocyte apoptotic process (GO:0097284) | 2.72671524 |
| 132 | positive regulation of cell killing (GO:0031343) | 2.70713343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.89805207 |
| 2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.64982689 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.90366790 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.70697629 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.50890016 |
| 6 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.48009156 |
| 7 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.31400412 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.23228076 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.21484658 |
| 10 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.16450719 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.14444924 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.12491886 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.12033940 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.11691444 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.04389779 |
| 16 | * MYB_26560356_Chip-Seq_TH2_Human | 2.99400187 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.88026120 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.61816730 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.55064674 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.52961533 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.39111587 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.35612421 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.28546806 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28366378 |
| 25 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.27193046 |
| 26 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.26783896 |
| 27 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26199530 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20217337 |
| 29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.13082268 |
| 30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.04080280 |
| 31 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.03233347 |
| 32 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.96821464 |
| 33 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92488405 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.90807844 |
| 35 | MAF_26560356_Chip-Seq_TH2_Human | 1.87094948 |
| 36 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.85897748 |
| 37 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.85644910 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.82923125 |
| 39 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.81699630 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.80998672 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78107872 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.77450869 |
| 43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.75293430 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70337594 |
| 45 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.66513042 |
| 46 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63944513 |
| 47 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.54462978 |
| 48 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47915762 |
| 49 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.47731035 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40144466 |
| 51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39998512 |
| 52 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.38979796 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34998303 |
| 54 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.31849746 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.30887052 |
| 56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30607149 |
| 57 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.28000581 |
| 58 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.27792255 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26582040 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26428628 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21680905 |
| 62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16676204 |
| 63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16509132 |
| 64 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16424173 |
| 65 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.15605427 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12535178 |
| 67 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.07361970 |
| 68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07165996 |
| 69 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06406432 |
| 70 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06080522 |
| 71 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03177613 |
| 72 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.03043639 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01286771 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00588648 |
| 75 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.00156409 |
| 76 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00002008 |
| 77 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99557233 |
| 78 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97521651 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96233667 |
| 80 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.95929935 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95893560 |
| 82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94820225 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94611862 |
| 84 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93879368 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93391362 |
| 86 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.91916722 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90590397 |
| 88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90456441 |
| 89 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.88604944 |
| 90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88226917 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88163721 |
| 92 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86581717 |
| 93 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.86443646 |
| 94 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.84974653 |
| 95 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84219772 |
| 96 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.83942639 |
| 97 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.83531639 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81678751 |
| 99 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81387230 |
| 100 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.81002524 |
| 101 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80488246 |
| 102 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79862803 |
| 103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79660692 |
| 104 | GATA3_26560356_Chip-Seq_TH1_Human | 0.79261702 |
| 105 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78336221 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78087604 |
| 107 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77101190 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.75703286 |
| 109 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.75264791 |
| 110 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.72562817 |
| 111 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.71716195 |
| 112 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71508478 |
| 113 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70945351 |
| 114 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.70244588 |
| 115 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.69559093 |
| 116 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.69257928 |
| 117 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69002981 |
| 118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.68403117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.37471528 |
| 2 | MP0005671_abnormal_response_to | 3.58898244 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.14851779 |
| 4 | MP0000685_abnormal_immune_system | 3.13097731 |
| 5 | MP0003300_gastrointestinal_ulcer | 3.08517448 |
| 6 | MP0003724_increased_susceptibility_to | 2.97474432 |
| 7 | MP0002166_altered_tumor_susceptibility | 2.94426039 |
| 8 | MP0001800_abnormal_humoral_immune | 2.79898014 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.57418359 |
| 10 | MP0001873_stomach_inflammation | 2.50995381 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.50567563 |
| 12 | MP0003436_decreased_susceptibility_to | 2.48573924 |
| 13 | MP0009785_altered_susceptibility_to | 2.48097201 |
| 14 | MP0005387_immune_system_phenotype | 2.47131728 |
| 15 | MP0001790_abnormal_immune_system | 2.47131728 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.46323328 |
| 17 | MP0002723_abnormal_immune_serum | 2.45908494 |
| 18 | MP0002398_abnormal_bone_marrow | 2.44484566 |
| 19 | MP0001819_abnormal_immune_cell | 2.43422619 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.36635896 |
| 21 | MP0003303_peritoneal_inflammation | 2.32728649 |
| 22 | MP0002006_tumorigenesis | 2.32608581 |
| 23 | MP0005025_abnormal_response_to | 2.28493528 |
| 24 | MP0002405_respiratory_system_inflammati | 2.26639112 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.25290015 |
| 26 | MP0004947_skin_inflammation | 2.24259640 |
| 27 | MP0000703_abnormal_thymus_morphology | 2.21114741 |
| 28 | MP0010155_abnormal_intestine_physiology | 2.14439244 |
| 29 | MP0000716_abnormal_immune_system | 2.09914770 |
| 30 | MP0000465_gastrointestinal_hemorrhage | 2.04198228 |
| 31 | MP0002722_abnormal_immune_system | 2.02236207 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 2.00825338 |
| 33 | MP0006082_CNS_inflammation | 1.98598322 |
| 34 | MP0004510_myositis | 1.98347279 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.97312038 |
| 36 | MP0003866_abnormal_defecation | 1.95498483 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.88756395 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.85966109 |
| 39 | MP0002419_abnormal_innate_immunity | 1.82068537 |
| 40 | MP0002429_abnormal_blood_cell | 1.76457056 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.75000121 |
| 42 | MP0009278_abnormal_bone_marrow | 1.68922335 |
| 43 | MP0001853_heart_inflammation | 1.67928480 |
| 44 | MP0001851_eye_inflammation | 1.65080299 |
| 45 | MP0001879_abnormal_lymphatic_vessel | 1.64610901 |
| 46 | MP0002933_joint_inflammation | 1.63540277 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.56326617 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.56326617 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.55343466 |
| 50 | MP0003448_altered_tumor_morphology | 1.36931528 |
| 51 | MP0006054_spinal_hemorrhage | 1.35151953 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.28586470 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.28436152 |
| 54 | MP0010234_abnormal_vibrissa_follicle | 1.25431495 |
| 55 | MP0000858_altered_metastatic_potential | 1.22121888 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.21421280 |
| 57 | MP0003828_pulmonary_edema | 1.18547132 |
| 58 | MP0000490_abnormal_crypts_of | 1.17705152 |
| 59 | MP0005451_abnormal_body_composition | 1.16023508 |
| 60 | MP0004381_abnormal_hair_follicle | 1.14584400 |
| 61 | MP0005310_abnormal_salivary_gland | 1.10428976 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.05934012 |
| 63 | MP0008469_abnormal_protein_level | 1.04507617 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.02756820 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.00592438 |
| 66 | MP0008260_abnormal_autophagy | 1.00304312 |
| 67 | MP0004883_abnormal_blood_vessel | 0.97941075 |
| 68 | MP0008961_abnormal_basal_metabolism | 0.97170600 |
| 69 | MP0003566_abnormal_cell_adhesion | 0.96699517 |
| 70 | * MP0002019_abnormal_tumor_incidence | 0.87630713 |
| 71 | MP0000343_altered_response_to | 0.86848477 |
| 72 | MP0000249_abnormal_blood_vessel | 0.85030983 |
| 73 | MP0003172_abnormal_lysosome_physiology | 0.84776105 |
| 74 | MP0002009_preneoplasia | 0.83809781 |
| 75 | MP0004130_abnormal_muscle_cell | 0.83465274 |
| 76 | MP0003191_abnormal_cellular_cholesterol | 0.82516907 |
| 77 | MP0003183_abnormal_peptide_metabolism | 0.81152257 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 0.80434632 |
| 79 | MP0008057_abnormal_DNA_replication | 0.79318184 |
| 80 | MP0005076_abnormal_cell_differentiation | 0.79048762 |
| 81 | MP0008004_abnormal_stomach_pH | 0.72583628 |
| 82 | MP0005075_abnormal_melanosome_morpholog | 0.72533820 |
| 83 | MP0000569_abnormal_digit_pigmentation | 0.70367326 |
| 84 | MP0003091_abnormal_cell_migration | 0.70190326 |
| 85 | MP0003045_fibrosis | 0.69727697 |
| 86 | MP0002693_abnormal_pancreas_physiology | 0.69046332 |
| 87 | MP0009763_increased_sensitivity_to | 0.68457077 |
| 88 | MP0005164_abnormal_response_to | 0.68444584 |
| 89 | * MP0001216_abnormal_epidermal_layer | 0.66438547 |
| 90 | MP0002132_abnormal_respiratory_system | 0.65737789 |
| 91 | MP0003279_aneurysm | 0.65456765 |
| 92 | MP0002332_abnormal_exercise_endurance | 0.65275561 |
| 93 | MP0003690_abnormal_glial_cell | 0.65034755 |
| 94 | MP0009764_decreased_sensitivity_to | 0.64844271 |
| 95 | * MP0005023_abnormal_wound_healing | 0.62866037 |
| 96 | MP0000015_abnormal_ear_pigmentation | 0.62606912 |
| 97 | MP0005174_abnormal_tail_pigmentation | 0.62475656 |
| 98 | MP0003943_abnormal_hepatobiliary_system | 0.62423407 |
| 99 | MP0003795_abnormal_bone_structure | 0.58432027 |
| 100 | MP0000477_abnormal_intestine_morphology | 0.57036955 |
| 101 | MP0005166_decreased_susceptibility_to | 0.56944529 |
| 102 | * MP0001191_abnormal_skin_condition | 0.56838559 |
| 103 | MP0001663_abnormal_digestive_system | 0.56451926 |
| 104 | MP0010307_abnormal_tumor_latency | 0.55964725 |
| 105 | MP0000383_abnormal_hair_follicle | 0.53875149 |
| 106 | MP0000767_abnormal_smooth_muscle | 0.52637632 |
| 107 | MP0004185_abnormal_adipocyte_glucose | 0.52462096 |
| 108 | MP0009931_abnormal_skin_appearance | 0.52451584 |
| 109 | MP0001243_abnormal_dermal_layer | 0.52341884 |
| 110 | MP0002796_impaired_skin_barrier | 0.52143681 |
| 111 | MP0000609_abnormal_liver_physiology | 0.51915933 |
| 112 | MP0005390_skeleton_phenotype | 0.51357093 |
| 113 | MP0002086_abnormal_extraembryonic_tissu | 0.50712352 |
| 114 | MP0002128_abnormal_blood_circulation | 0.50516182 |
| 115 | MP0009115_abnormal_fat_cell | 0.50471770 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.50425471 |
| 117 | MP0004484_altered_response_of | 0.49707510 |
| 118 | MP0001765_abnormal_ion_homeostasis | 0.49116855 |
| 119 | MP0001348_abnormal_lacrimal_gland | 0.47511770 |
| 120 | MP0000604_amyloidosis | 0.47306109 |
| 121 | MP0002136_abnormal_kidney_physiology | 0.45631100 |
| 122 | MP0003075_altered_response_to | 0.43580495 |
| 123 | MP0003656_abnormal_erythrocyte_physiolo | 0.42683112 |
| 124 | MP0002168_other_aberrant_phenotype | 0.41780320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.76637360 |
| 2 | Abnormality of T cell number (HP:0011839) | 5.55394483 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.45157309 |
| 4 | Abnormality of the nasal mucosa (HP:0000433) | 4.48433849 |
| 5 | Abnormality of T cells (HP:0002843) | 4.42186662 |
| 6 | Myositis (HP:0100614) | 4.39259449 |
| 7 | Recurrent fungal infections (HP:0002841) | 4.36107367 |
| 8 | Recurrent bronchitis (HP:0002837) | 4.20936140 |
| 9 | Spontaneous hematomas (HP:0007420) | 4.18803319 |
| 10 | Recurrent viral infections (HP:0004429) | 4.14749575 |
| 11 | IgM deficiency (HP:0002850) | 4.09096725 |
| 12 | Stomatitis (HP:0010280) | 4.08866701 |
| 13 | Chronic otitis media (HP:0000389) | 4.07291077 |
| 14 | Severe combined immunodeficiency (HP:0004430) | 4.03323590 |
| 15 | Eczematoid dermatitis (HP:0000976) | 4.02868939 |
| 16 | Nasal polyposis (HP:0100582) | 4.01999281 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.89985057 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.72738803 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.72738803 |
| 20 | Combined immunodeficiency (HP:0005387) | 3.68958296 |
| 21 | Autoimmune hemolytic anemia (HP:0001890) | 3.56883954 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.54730422 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.46580465 |
| 24 | Abnormality of the fingertips (HP:0001211) | 3.34614050 |
| 25 | Increased IgE level (HP:0003212) | 3.33069631 |
| 26 | Orchitis (HP:0100796) | 3.32420283 |
| 27 | IgG deficiency (HP:0004315) | 3.24965057 |
| 28 | Inflammation of the large intestine (HP:0002037) | 3.24450822 |
| 29 | Gastrointestinal inflammation (HP:0004386) | 3.21404869 |
| 30 | Retrobulbar optic neuritis (HP:0100654) | 3.21349450 |
| 31 | Optic neuritis (HP:0100653) | 3.21349450 |
| 32 | Abnormality of T cell physiology (HP:0011840) | 3.18615485 |
| 33 | Thyroiditis (HP:0100646) | 3.15135834 |
| 34 | B lymphocytopenia (HP:0010976) | 3.13971938 |
| 35 | Abnormality of B cell number (HP:0010975) | 3.13971938 |
| 36 | Pustule (HP:0200039) | 3.12177071 |
| 37 | Hemoptysis (HP:0002105) | 3.10995415 |
| 38 | Chronic diarrhea (HP:0002028) | 3.09538787 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 3.06128173 |
| 40 | Hematochezia (HP:0002573) | 3.05285066 |
| 41 | Thrombocytosis (HP:0001894) | 2.93725710 |
| 42 | Eosinophilia (HP:0001880) | 2.88730021 |
| 43 | Abnormality of eosinophils (HP:0001879) | 2.87578410 |
| 44 | Arterial thrombosis (HP:0004420) | 2.87099023 |
| 45 | Leukocytosis (HP:0001974) | 2.86900262 |
| 46 | Prolonged bleeding time (HP:0003010) | 2.83573907 |
| 47 | Meningitis (HP:0001287) | 2.82634856 |
| 48 | Lymphopenia (HP:0001888) | 2.82337879 |
| 49 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.74056491 |
| 50 | Recurrent abscess formation (HP:0002722) | 2.72336442 |
| 51 | Vasculitis (HP:0002633) | 2.71756494 |
| 52 | Colitis (HP:0002583) | 2.70949466 |
| 53 | Increased density of long bones (HP:0006392) | 2.65722553 |
| 54 | IgA deficiency (HP:0002720) | 2.65660824 |
| 55 | Verrucae (HP:0200043) | 2.59087180 |
| 56 | Papilloma (HP:0012740) | 2.59087180 |
| 57 | Epistaxis (HP:0000421) | 2.54599785 |
| 58 | Granulocytopenia (HP:0001913) | 2.53926536 |
| 59 | Pulmonary embolism (HP:0002204) | 2.51911720 |
| 60 | Agammaglobulinemia (HP:0004432) | 2.49061393 |
| 61 | Joint swelling (HP:0001386) | 2.47513889 |
| 62 | Keratoconjunctivitis sicca (HP:0001097) | 2.45636759 |
| 63 | Recurrent skin infections (HP:0001581) | 2.44399122 |
| 64 | Chest pain (HP:0100749) | 2.43741488 |
| 65 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.42823652 |
| 66 | Cellulitis (HP:0100658) | 2.40645765 |
| 67 | Acute hepatic failure (HP:0006554) | 2.39298010 |
| 68 | Anorexia (HP:0002039) | 2.39160265 |
| 69 | Pulmonary infiltrates (HP:0002113) | 2.37495844 |
| 70 | Gingivitis (HP:0000230) | 2.35862949 |
| 71 | Mediastinal lymphadenopathy (HP:0100721) | 2.35229927 |
| 72 | Papilledema (HP:0001085) | 2.31414982 |
| 73 | Bronchitis (HP:0012387) | 2.29890638 |
| 74 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.29869460 |
| 75 | Polycythemia (HP:0001901) | 2.28529868 |
| 76 | Interstitial pulmonary disease (HP:0006530) | 2.26738713 |
| 77 | Hypergammaglobulinemia (HP:0010702) | 2.24244082 |
| 78 | Persistence of primary teeth (HP:0006335) | 2.23582764 |
| 79 | Slow saccadic eye movements (HP:0000514) | 2.22655657 |
| 80 | Encephalitis (HP:0002383) | 2.21491419 |
| 81 | Lymphoma (HP:0002665) | 2.18914399 |
| 82 | Keratoconjunctivitis (HP:0001096) | 2.17555702 |
| 83 | Chronic sinusitis (HP:0011109) | 2.16191056 |
| 84 | Abnormal platelet function (HP:0011869) | 2.16131999 |
| 85 | Impaired platelet aggregation (HP:0003540) | 2.16131999 |
| 86 | Recurrent bacterial skin infections (HP:0005406) | 2.12964707 |
| 87 | Abnormality of the pleura (HP:0002103) | 2.12491940 |
| 88 | Urticaria (HP:0001025) | 2.11451235 |
| 89 | Stomach cancer (HP:0012126) | 2.10504607 |
| 90 | Abnormal platelet volume (HP:0011876) | 2.09273941 |
| 91 | Keratitis (HP:0000491) | 2.08863588 |
| 92 | Hypoproteinemia (HP:0003075) | 2.08612722 |
| 93 | Gastrointestinal infarctions (HP:0005244) | 2.07839957 |
| 94 | Chronic obstructive pulmonary disease (HP:0006510) | 2.06157619 |
| 95 | Obstructive lung disease (HP:0006536) | 2.06157619 |
| 96 | Basal cell carcinoma (HP:0002671) | 2.05779890 |
| 97 | Bicuspid aortic valve (HP:0001647) | 2.05334437 |
| 98 | Fatigue (HP:0012378) | 2.00809599 |
| 99 | Hypoplasia of the thymus (HP:0000778) | 1.99573543 |
| 100 | Hypochromic anemia (HP:0001931) | 1.97939844 |
| 101 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.97721964 |
| 102 | Increased IgM level (HP:0003496) | 1.96196394 |
| 103 | Skin ulcer (HP:0200042) | 1.95002697 |
| 104 | Gangrene (HP:0100758) | 1.94370411 |
| 105 | Esophageal varix (HP:0002040) | 1.92555137 |
| 106 | Cheilitis (HP:0100825) | 1.92286396 |
| 107 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.91865521 |
| 108 | Polyneuropathy (HP:0001271) | 1.90980516 |
| 109 | Glomerulopathy (HP:0100820) | 1.90456604 |
| 110 | Gingival bleeding (HP:0000225) | 1.90248199 |
| 111 | Alveolar cell carcinoma (HP:0006519) | 1.88505022 |
| 112 | Vertigo (HP:0002321) | 1.87907041 |
| 113 | Aortic aneurysm (HP:0004942) | 1.87754228 |
| 114 | Microcytic anemia (HP:0001935) | 1.87416585 |
| 115 | Abnormality of the prostate (HP:0008775) | 1.86729580 |
| 116 | Viral hepatitis (HP:0006562) | 1.86413046 |
| 117 | Periodontitis (HP:0000704) | 1.85744761 |
| 118 | Hemiplegia (HP:0002301) | 1.85049144 |
| 119 | Cutis marmorata (HP:0000965) | 1.84335810 |
| 120 | Abnormality of the endocardium (HP:0004306) | 1.84157735 |
| 121 | Sepsis (HP:0100806) | 1.82820472 |
| 122 | Petechiae (HP:0000967) | 1.81478826 |
| 123 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.81418317 |
| 124 | Increased CSF protein (HP:0002922) | 1.80706685 |
| 125 | Osteomyelitis (HP:0002754) | 1.79882759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.97170249 |
| 2 | TXK | 4.69049611 |
| 3 | JAK3 | 3.43664847 |
| 4 | FGFR4 | 3.09713378 |
| 5 | KDR | 3.04176110 |
| 6 | ZAP70 | 2.73116404 |
| 7 | ITK | 2.64266211 |
| 8 | IKBKE | 2.58520448 |
| 9 | RIPK4 | 2.58322801 |
| 10 | TYK2 | 2.57029995 |
| 11 | STK10 | 2.56677367 |
| 12 | TGFBR2 | 2.41496151 |
| 13 | TIE1 | 2.39106184 |
| 14 | EEF2K | 2.36096752 |
| 15 | PRPF4B | 2.32278305 |
| 16 | FGFR3 | 2.32097831 |
| 17 | MAP3K10 | 1.91000127 |
| 18 | TBK1 | 1.89598482 |
| 19 | MAP3K14 | 1.87588885 |
| 20 | JAK1 | 1.85472210 |
| 21 | PKN2 | 1.85281872 |
| 22 | TGFBR1 | 1.75271210 |
| 23 | TEC | 1.73226593 |
| 24 | KIT | 1.70921498 |
| 25 | CAMKK2 | 1.69492283 |
| 26 | NLK | 1.69224370 |
| 27 | LCK | 1.65121036 |
| 28 | GRK6 | 1.53200677 |
| 29 | CSK | 1.49672745 |
| 30 | HCK | 1.44430278 |
| 31 | TRIB3 | 1.38177816 |
| 32 | LRRK2 | 1.37487889 |
| 33 | BTK | 1.34378918 |
| 34 | FES | 1.28957090 |
| 35 | MAP2K3 | 1.23877967 |
| 36 | SYK | 1.22594945 |
| 37 | MAP3K13 | 1.15352194 |
| 38 | IKBKB | 1.14264928 |
| 39 | PIK3CG | 1.13616607 |
| 40 | EPHB1 | 1.09197202 |
| 41 | CAMKK1 | 1.08501636 |
| 42 | SIK3 | 1.08285249 |
| 43 | BLK | 1.07925969 |
| 44 | JAK2 | 1.06567948 |
| 45 | MARK3 | 1.04171390 |
| 46 | RPS6KA4 | 1.01569178 |
| 47 | PTK6 | 1.01228048 |
| 48 | MST4 | 0.96296403 |
| 49 | RIPK1 | 0.95555727 |
| 50 | BMPR2 | 0.95194276 |
| 51 | NME2 | 0.92754884 |
| 52 | PIM1 | 0.91381470 |
| 53 | MAP3K7 | 0.89041535 |
| 54 | IRAK1 | 0.88411228 |
| 55 | FRK | 0.88193296 |
| 56 | TTN | 0.87899303 |
| 57 | CHUK | 0.86776517 |
| 58 | FGR | 0.84081055 |
| 59 | ERN1 | 0.82654636 |
| 60 | CLK1 | 0.81433477 |
| 61 | PRKCQ | 0.80552449 |
| 62 | CSF1R | 0.78069546 |
| 63 | SIK2 | 0.76228163 |
| 64 | CDK12 | 0.74527479 |
| 65 | MAP3K3 | 0.73075910 |
| 66 | EPHA3 | 0.72331934 |
| 67 | IRAK4 | 0.70494507 |
| 68 | TAOK1 | 0.65708291 |
| 69 | TESK2 | 0.64998441 |
| 70 | MAP2K6 | 0.64349721 |
| 71 | LYN | 0.63983637 |
| 72 | CDK4 | 0.63582225 |
| 73 | CDK6 | 0.63385514 |
| 74 | DMPK | 0.62838138 |
| 75 | PDGFRB | 0.61960135 |
| 76 | SGK2 | 0.60255613 |
| 77 | FLT3 | 0.59393409 |
| 78 | SGK3 | 0.55212318 |
| 79 | PTK2B | 0.54035380 |
| 80 | MAPK12 | 0.53758426 |
| 81 | STK38 | 0.52368018 |
| 82 | YES1 | 0.49962880 |
| 83 | HIPK2 | 0.49786825 |
| 84 | CDK9 | 0.49602841 |
| 85 | ALK | 0.49441689 |
| 86 | TNK2 | 0.48871236 |
| 87 | RPS6KB2 | 0.48498633 |
| 88 | GRK7 | 0.48447638 |
| 89 | TYRO3 | 0.48124300 |
| 90 | FGFR2 | 0.47552872 |
| 91 | * PDK1 | 0.47275685 |
| 92 | MAP3K11 | 0.47216310 |
| 93 | MAPK11 | 0.46113108 |
| 94 | EGFR | 0.43424550 |
| 95 | STK4 | 0.43101587 |
| 96 | NEK6 | 0.42522903 |
| 97 | MARK2 | 0.40836951 |
| 98 | SMG1 | 0.39755088 |
| 99 | MAPK7 | 0.39587966 |
| 100 | MAP3K8 | 0.39322045 |
| 101 | IGF1R | 0.37709885 |
| 102 | TSSK6 | 0.37395681 |
| 103 | STK11 | 0.36091598 |
| 104 | WNK1 | 0.35894178 |
| 105 | MAPK4 | 0.35386046 |
| 106 | CDC42BPA | 0.34752383 |
| 107 | MAP3K2 | 0.33794723 |
| 108 | NEK2 | 0.33043699 |
| 109 | TAOK2 | 0.32191957 |
| 110 | FGFR1 | 0.32054195 |
| 111 | CAMK4 | 0.31872116 |
| 112 | RPS6KC1 | 0.28242926 |
| 113 | FYN | 0.28223365 |
| 114 | TRPM7 | 0.28188056 |
| 115 | RET | 0.27930509 |
| 116 | RPS6KA5 | 0.27838319 |
| 117 | MAPKAPK2 | 0.27164267 |
| 118 | INSR | 0.27131002 |
| 119 | MAP3K1 | 0.27107472 |
| 120 | BRD4 | 0.26976690 |
| 121 | TAOK3 | 0.25509052 |
| 122 | RPS6KA6 | 0.25337786 |
| 123 | PRKD2 | 0.24718603 |
| 124 | PASK | 0.23923470 |
| 125 | MAPK3 | 0.22223035 |
| 126 | MELK | 0.21904357 |
| 127 | PRKD1 | 0.21793486 |
| 128 | MAPKAPK3 | 0.21767328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.43393220 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.19816779 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.01687609 |
| 4 | Measles_Homo sapiens_hsa05162 | 2.65303311 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.61304224 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.50335685 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25061684 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.19839053 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.18471034 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.12078319 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.01983824 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.00876099 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.99628708 |
| 14 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.90966749 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.88920344 |
| 16 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.71667276 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.71048694 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.68536146 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64797806 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.58055547 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52182759 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.40987567 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.40091414 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39380711 |
| 25 | Hepatitis B_Homo sapiens_hsa05161 | 1.39265061 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39007572 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.37548705 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.36266726 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.36131611 |
| 30 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.34710648 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32225756 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.30534284 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.29951301 |
| 34 | Platelet activation_Homo sapiens_hsa04611 | 1.26308361 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.25451070 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.24478452 |
| 37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.23749341 |
| 38 | HTLV-I infection_Homo sapiens_hsa05166 | 1.21931797 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.17733242 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.15474934 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15177093 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13749215 |
| 43 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.05355521 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 1.05128860 |
| 45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.04689880 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.04104837 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.99348401 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.98845162 |
| 49 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.97469918 |
| 50 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.95138788 |
| 51 | Colorectal cancer_Homo sapiens_hsa05210 | 0.93974666 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 0.93922613 |
| 53 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.92381531 |
| 54 | Tuberculosis_Homo sapiens_hsa05152 | 0.92362750 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.87380231 |
| 56 | Asthma_Homo sapiens_hsa05310 | 0.85180116 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85169489 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.83148536 |
| 59 | Ribosome_Homo sapiens_hsa03010 | 0.82794011 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80371351 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.79908015 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79559413 |
| 63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77995459 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77324883 |
| 65 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67822337 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65107030 |
| 67 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64944095 |
| 68 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62072643 |
| 69 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62071169 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.60992622 |
| 71 | Adherens junction_Homo sapiens_hsa04520 | 0.60784812 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60504639 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.59699772 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59134850 |
| 75 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57533424 |
| 76 | Focal adhesion_Homo sapiens_hsa04510 | 0.57061503 |
| 77 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56205241 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54795237 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54589099 |
| 80 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52768025 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.52262998 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51400298 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51170185 |
| 84 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51025652 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50784678 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49606111 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49278447 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48656159 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48185506 |
| 90 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48044460 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47784514 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47552531 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45899643 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.45625553 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45331572 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43701662 |
| 97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43125061 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39747750 |
| 99 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.39299549 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39250704 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39117391 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38592279 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.34936025 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | 0.34647996 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34291581 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33183937 |
| 107 | Glioma_Homo sapiens_hsa05214 | 0.33103542 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32946980 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31135117 |
| 110 | Spliceosome_Homo sapiens_hsa03040 | 0.29839014 |
| 111 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.29548771 |
| 112 | ABC transporters_Homo sapiens_hsa02010 | 0.29525831 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29228452 |
| 114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.28527789 |
| 115 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26985861 |
| 116 | Circadian rhythm_Homo sapiens_hsa04710 | 0.26652564 |
| 117 | DNA replication_Homo sapiens_hsa03030 | 0.24763199 |

